Radiopharmacy Forum Dresden 2026
Under the theme “From Isotope to Patient – Where the Radiopharmaceutical Value Chain Meets”, the forum will bring together stakeholders from industry, research, healthcare, policy and regulatory bodies to discuss the future of radiopharmacy across the entire value chain.
- Location
- Dresden, information on the exact venue will be announced shortly
- Event date
- October 7 - 8, 2026
- Deadline
- 02.10.2026
- Audience
- Research, Industry, Healthcare Providers, Policy Makers
- Sectors
- Radiopharmacy
- Country/Region
- International
- Organizer
- Helmholtz Center Dresden-Rossendorf (HZDR) powered by nukliD®
- Price
- free of charge
Information and objective
Join leading experts from industry, research, clinics, policy and innovation ecosystems for two days dedicated to the future of radiopharmaceutical innovation.
Hosted in one of Europe’s fastest-growing radiopharmaceutical regions, the Radiopharmacy Forum Dresden 2026 brings together stakeholders from across the entire value chain to discuss innovation, isotope supply, clinical translation, infrastructure, regulation and patient access.
The event is organized in close connection with the growing nukliD® ecosystem and highlights Dresden and Central Germany as an emerging hub for radiopharmaceutical innovation and production.
If you are interested in partnership opportunities, sponsorship or exhibition space, please contact Dr. Peggy Jungke from Helmholtz Center Dresden-Rossendorf.
Agenda
Two days, four main topics and numerous opportunities for professional exchange. The agenda covers current developments in radiopharmacy, theranostics, clinical translation, regulation and international value chains.
- Session I – Isotope Supply & Production Technologies
- Session II – Radiopharmaceutical Innovation & Theranostics
- Session III – Clinical Translation & Infrastructure
- Session IV – Policy, Regulation & Market Access
On the evening of October 7, 2026, participants are invited to join an exclusive fireside chat bringing together leaders from industry, research, healthcare and policy. On October 8, 2026, selected partners will open their facilities for an industry tour, providing exclusive insights into radiopharmaceutical research, development, manufacturing and clinical translation.
Register
Under the theme “From Isotope to Patient – Where the Radiopharmaceutical Value Chain Meets”, the forum will bring together stakeholders from industry, research, healthcare, policy and regulatory bodies to discuss the future of radiopharmacy across the entire value chain.